WHCI
WST icon

W.H. Cornerstone Investments’s West Pharmaceutical WST Stock Holding History

W.H. Cornerstone Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-788
Closed -$236K – 128
2024
Q3 		$236K Sell
788
-440
-36% -$135K 0.16% 109
2024
Q2 		$404K Sell
1,228
-527
-30% -$186K 0.29% 72
2024
Q1 		$694K Buy
1,755
+7
+0.4% +$2.59K 0.5% 56
2023
Q4 		$615K Buy
1,748
+1,213
+227% +$429K 0.49% 55
2023
Q3 		$201K Buy
+535
New +$207K 0.18% 127

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

W.H. Cornerstone Investments's WST Position: Q4 2024 in Review

W.H. Cornerstone Investments sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 788 shares — an estimated $236K sold.

W.H. Cornerstone Investments first reported a position in WST in Q3 2023 and held it in 5 quarters. The position peaked at $694K in Q1 2024. 747 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • W.H. Cornerstone Investments reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • W.H. Cornerstone Investments sold 788 West Pharmaceutical shares in Q4 2024, an estimated $236K.
  • W.H. Cornerstone Investments first reported a position in West Pharmaceutical in Q3 2023 and held it in 5 quarters.
  • W.H. Cornerstone Investments's West Pharmaceutical position peaked at $694K in Q1 2024.
  • 747 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on W.H. Cornerstone Investments's 13F filing for Q4 2024, filed 30 Jan 2025.